Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.
Centro Nacional de Investigaciones Cardiovasculares (CNIC-ISCIII), Madrid, Spain.
Microbiol Spectr. 2022 Dec 21;10(6):e0389322. doi: 10.1128/spectrum.03893-22. Epub 2022 Dec 1.
Interferon-stimulated gene 15 (ISG15) is a 15-kDa ubiquitin-like modifier that binds to target proteins in a process termed ISGylation. ISG15, first described as an antiviral molecule against many viruses, participates in numerous cellular processes, from immune modulation to the regulation of genome stability. Interestingly, the role of ISG15 as a regulator of cell metabolism has recently gained strength. We previously described ISG15 as a regulator of mitochondrial functions in bone marrow-derived macrophages (BMDMs) in the context of (VACV) infection. Here, we demonstrate that ISG15 regulates lipid metabolism in BMDMs and that ISG15 is necessary to modulate the impact of VACV infection on lipid metabolism. We show that BMDMs demonstrate alterations in the levels of several key proteins of lipid metabolism that result in differences in the lipid profile compared with (wild-type [WT]) BMDMs. Specifically, BMDMs present reduced levels of neutral lipids, reflected by decreased lipid droplet number. These alterations are linked to increased levels of lipases and are independent of enhanced fatty acid oxidation (FAO). Moreover, we demonstrate that VACV causes a dysregulation in the proteomes of BMDMs and alterations in the lipid content of these cells, which appear exacerbated in BMDMs. Such metabolic changes are likely caused by increased expression of the metabolic regulators peroxisome proliferator-activated receptor-γ (PPARγ) and PPARγ coactivator-1α (PGC-1α). In summary, our results highlight that ISG15 controls BMDM lipid metabolism during viral infections, suggesting that ISG15 is an important host factor to restrain VACV impact on cell metabolism. The functions of ISG15 are continuously expanding, and growing evidence supports its role as a relevant modulator of cell metabolism. In this work, we highlight how the absence of ISG15 impacts macrophage lipid metabolism in the context of viral infections and how poxviruses modulate metabolism to ensure successful replication. Our results open the door to new advances in the comprehension of macrophage immunometabolism and the interaction between VACV and the host.
干扰素刺激基因 15(ISG15)是一种 15kDa 的泛素样修饰物,它通过一种称为 ISGylation 的过程与靶蛋白结合。ISG15 最初被描述为一种针对多种病毒的抗病毒分子,参与了从免疫调节到基因组稳定性调节的许多细胞过程。有趣的是,ISG15 作为细胞代谢调节剂的作用最近得到了加强。我们之前描述了 ISG15 作为骨髓来源的巨噬细胞(BMDMs)中(VACV)感染背景下线粒体功能的调节剂。在这里,我们证明 ISG15 调节 BMDM 中的脂质代谢,并且 ISG15 对于调节 VACV 感染对脂质代谢的影响是必需的。我们表明, BMDMs 表现出几种关键脂质代谢蛋白水平的改变,导致与 (野生型[WT])BMDMs 相比脂质谱的差异。具体而言, BMDMs 表现出中性脂质水平降低,反映为脂质滴数量减少。这些改变与脂肪酶水平升高有关,并且与增强的脂肪酸氧化(FAO)无关。此外,我们证明 VACV 导致 BMDM 中的蛋白质组失调和这些细胞中脂质含量的改变,这些改变在 BMDMs 中似乎更加严重。这种代谢变化可能是由代谢调节剂过氧化物酶体增殖物激活受体-γ(PPARγ)和过氧化物酶体增殖物激活受体-γ共激活物-1α(PGC-1α)的表达增加引起的。总之,我们的结果强调了 ISG15 在病毒感染期间控制 BMDM 脂质代谢,表明 ISG15 是限制 VACV 对细胞代谢影响的重要宿主因素。ISG15 的功能不断扩展,越来越多的证据支持其作为细胞代谢相关调节剂的作用。在这项工作中,我们强调了在病毒感染的情况下缺乏 ISG15 如何影响巨噬细胞脂质代谢,以及痘病毒如何调节代谢以确保成功复制。我们的结果为理解巨噬细胞免疫代谢以及 VACV 与宿主之间的相互作用开辟了新的进展。